MedPath

Comparision of 2 drugs( hyperbaric bupivacaine and hyperbaric ropivacaine) used in spinal anaesthesia for caeserean section in patients with pregnancy induced hypertensio

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/11/060021
Lead Sponsor
RAJESHKUMAR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Hypertensive disorders of pregnancy planned for elective caesarean section under Spinal Anaesthesia

Exclusion Criteria

Hypersensitivity to any of the study drugs,

Patients with spinal deformity,

Patients with coagulopathy,

Short stature (less than 140 cms),

Elderly primigravida,

Precious pregnancy,

Other comorbidities like Diabetes Mellitus, CAD, Congenital heart diseases, Valvular heart diseases etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the incidence of hypotension with Inj. 0.75% Hyperbaric Ropivacaine as compared to Inj. 0.5% Hyperbaric Bupivacaine during Spinal Anaesthesia for Caesarean Section in PIHTimepoint: Untill patient is shifted to recovery room
Secondary Outcome Measures
NameTimeMethod
1)To compare the onset and regression of sensory block up to T10 between 2 groups. <br/ ><br>2)To compare the onset and regression of motor block between 2 groups. <br/ ><br>3)To compare incidence of side effects between 2 groups.Timepoint: untill regression of sensory block and motor block in recovery room
© Copyright 2025. All Rights Reserved by MedPath